ProMIS Neurosciences (PMN) Balance Sheet: Assets & Liabilities

ProMIS Neurosciences (PMN) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), ProMIS Neurosciences reported total assets of CAD 9.18M and total liabilities of CAD 10.44M. Shareholders' equity was negative at −CAD 1.26M, meaning liabilities exceed assets. Total debt stood at CAD 0.00 against CAD 6.15M in cash and short-term investments, a net cash position of CAD 6.15M.

ProMIS Neurosciences Balance Sheet Analysis

Values in billions CAD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for ProMIS Neurosciences, Inc. (PMN) - Annual data in billions CAD
Breakdown	FY 2025	FY 2024	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Mar 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Mar 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	0.01	0.01	0.01	0.01	0.01	0.02	0.00	0.00	0.00	0.00	0.00
Short-Term Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	0.01	0.01	0.01	0.01	0.01	0.02	0.00	0.00	0.00	0.00	0.00
Accounts Receivable	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	-	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00
Other Current Assets	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Current Assets	0.01	0.02	0.02	0.01	0.01	0.02	0.00	0.00	0.00	0.00	0.00
Non-Current Assets
Property, Plant & Equipment (Net)	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Investments	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Intangible Assets	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Non-Current Assets	0.00	0.00	-	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00
Total Non-Current Assets	0.00	0.00	-	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00
Total Assets	0.01	0.02	0.02	0.01	0.01	0.02	0.00	0.00	0.00	0.00	0.00
Current Liabilities
Accounts Payable	0.00	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accrued Liabilities	0.01	-	0.00	0.00	0.00	0.00	-	0.00	-	-	-
Other Current Liabilities	0.01	0.00	-	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00
Total Current Liabilities	0.01	0.00	0.00	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00
Non-Current Liabilities
Long-Term Debt	0.00	0.00	-	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00	0.01	0.00	-	0.00	0.00	0.00
Total Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00	0.01	0.00	-	0.00	0.00	0.00
Total Liabilities	0.01	0.00	0.00	0.01	0.01	0.02	0.00	0.00	0.00	0.00	0.00
Stockholders' Equity
Common Stock	0.00	0.00	-	0.00	0.00	0.00	0.05	0.04	0.05	0.05	0.04
Retained Earnings	-0.13	-0.09	-0.09	-0.09	-0.08	-0.08	-0.07	-0.06	-0.07	-0.06	-0.05
Accumulated Other Comprehensive Income	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.01	0.01	0.01	0.00
Additional Paid-in Capital	0.13	0.11	0.11	0.10	0.08	0.09	0.01	-	0.01	0.03	0.02
Shares Outstanding	0.00	-	0.00	0.00	0.00	0.00	-	-	-	-	-
Total Stockholders' Equity	0.00	0.02	0.02	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.00
Total Liabilities & Equity	9.18	0.02	0.02	0.01	0.01	0.02	0.00	-	0.00	0.00	0.00

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About ProMIS Neurosciences Balance Sheet

How much debt does ProMIS Neurosciences have?

ProMIS Neurosciences had total debt of CAD 0.00 as of Dec 31, 2025, against CAD 6.15M in cash and short-term investments. Total debt was CAD 0.00 a year earlier.

What are ProMIS Neurosciences's total assets?

ProMIS Neurosciences reported total assets of CAD 9.18M as of Dec 31, 2025, down 51.4% from CAD 18.91M a year earlier. Total liabilities were CAD 10.44M.

What is ProMIS Neurosciences's shareholders' equity?

ProMIS Neurosciences's shareholders' equity was negative at −CAD 1.26M as of Dec 31, 2025, so its liabilities exceeded its assets.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition